Truvestments Capital’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.9K | Buy |
650
+369
| +131% | +$20.4K | 0.01% | 451 |
|
|
2025
Q1 | $13.6K | Buy |
281
+150
| +115% | +$7.25K | ﹤0.01% | 608 |
|
|
2024
Q4 | $5.06K | Hold |
131
| – | – | ﹤0.01% | 699 |
|
|
2024
Q3 | $5.9K | Buy |
+131
| New | +$5.9K | ﹤0.01% | 661 |
|
|
2024
Q2 | – | Sell |
-131
| Closed | -$3.79K | – | 567 |
|
|
2024
Q1 | $3.79K | Hold |
131
| – | – | ﹤0.01% | 570 |
|
|
2023
Q4 | $3K | Hold |
131
| – | – | ﹤0.01% | 647 |
|
|
2023
Q3 | $2.19K | Hold |
131
| – | – | ﹤0.01% | 584 |
|
|
2023
Q2 | $3.62K | Hold |
131
| – | – | ﹤0.01% | 559 |
|
|
2023
Q1 | $3.01K | Sell |
131
-214
| -62% | -$4.92K | ﹤0.01% | 553 |
|
|
2022
Q4 | $3.76K | Hold |
345
| – | – | ﹤0.01% | 596 |
|
|
2022
Q3 | $3K | Hold |
345
| – | – | ﹤0.01% | 521 |
|
|
2022
Q2 | $3K | Buy |
+345
| New | +$3K | ﹤0.01% | 537 |
|
|
2022
Q1 | – | Sell |
-250
| Closed | -$9K | – | 448 |
|
|
2021
Q4 | $9K | Hold |
250
| – | – | ﹤0.01% | 411 |
|
|
2021
Q3 | $4K | Hold |
250
| – | – | ﹤0.01% | 480 |
|
|
2021
Q2 | $11K | Hold |
250
| – | – | 0.01% | 383 |
|
|
2021
Q1 | $6K | Buy |
250
+131
| +110% | +$3.14K | ﹤0.01% | 506 |
|
|
2020
Q4 | $2K | Buy |
+119
| New | +$2K | ﹤0.01% | 563 |
|
|
2020
Q3 | – | Sell |
-119
| Closed | -$2K | – | 490 |
|
|
2020
Q2 | $2K | Buy |
+119
| New | +$2K | ﹤0.01% | 516 |
|
|
2019
Q4 | – | Sell |
-119
| Closed | -$1K | – | 467 |
|
|
2019
Q3 | $1K | Hold |
119
| – | – | ﹤0.01% | 684 |
|
|
2019
Q2 | $1K | Hold |
119
| – | – | ﹤0.01% | 701 |
|
|
2019
Q1 | $1K | Buy |
+119
| New | +$1K | ﹤0.01% | 705 |
|
|
2018
Q3 | $3K | Buy |
+252
| New | +$3K | ﹤0.01% | 778 |
|